HNW / UHNW
Investable assets $1M+ through $30M+. Private-banking, wealth management, family office audiences.
Audience — Hard-to-Reach
The audiences no one else
can field.
HNW, UHNW, C-suite, niche clinicians, rare-disease patients, regulated professionals. When incidence is below 1% and the panel doesn’t exist, we go build it.
Low-incidence
Sub-1% cohorts routinely served
Bespoke recruit
Built for the brief, end-to-end
High-completion
Engaged, committed respondents
Cohorts available
Where the
depth lives.
Every cohort is continuously refreshed, routinely re-verified, and permission-managed.
C-suite
CEOs, CFOs, CMOs at companies $50M+ revenue — verified at the registrar level.
Rare-disease patients
Verified diagnosis, patient-advocacy partnerships, IRB-appropriate consent.
Regulated roles
Compliance officers, MLROs, radiation safety, FDA QA heads.
Public-sector leaders
Senior civil servants, elected officials, policy advisors.
On-demand bespoke
Named-account, industry-specific, territory-specific — built to your brief.
Verification
How we know they’re
real.
Verification is not a one-off gate — it’s a rhythm. Here is exactly what happens before a respondent is ever invited into your survey.
01 Identity
Enhanced KYC
Where appropriate: government ID, proof of address, employer.
02 Wealth
Asset proof band
HNW/UHNW verified via banking partner or self-attested with audit.
03 Diagnosis
Clinical partner
Rare-disease via patient-group partnerships, not open recruitment.
04 Role
Company registrar
C-suite verified via Companies House, SEC filings or equivalent.
05 Consent
Study-specific
Sensitive populations sign study-specific consent every engagement.
06 Privacy
Pseudonymisation
Identifiable data tokenised end-to-end by default.
What it’s good for
Use this audience when…
Continue exploring
Brief Our Specialist Team
Ready to sample
hard-to-reach audiences?
Tell us the audience profile, geography, and sample requirements. We'll come back within 2 hours with feasibility, timing, and a quote.